AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

We also talk about today’s DNA-related advances that use machine learning to design tailored Cas9 proteins, and multiple sequencing technologies to study mutation rates in four generations of the same ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...

Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.

Researchers say study underscores how psychedelics may help dial down inflammation and reset brain-immune interactions.